AMERICAN SHARED HOSPITAL SER (AMS) Fundamental Analysis & Valuation

NYSEARCA:AMS • US0295951059

Current stock price

1.35 USD
+0.02 (+1.5%)
Last:

This AMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AMS Profitability Analysis

1.1 Basic Checks

  • AMS had negative earnings in the past year.
  • In the past year AMS had a positive cash flow from operations.
  • AMS had positive earnings in 4 of the past 5 years.
  • In the past 5 years AMS always reported a positive cash flow from operatings.
AMS Yearly Net Income VS EBIT VS OCF VS FCFAMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

  • The Return On Assets of AMS (-2.80%) is worse than 62.00% of its industry peers.
  • AMS's Return On Equity of -6.46% is in line compared to the rest of the industry. AMS outperforms 43.00% of its industry peers.
Industry RankSector Rank
ROA -2.8%
ROE -6.46%
ROIC N/A
ROA(3y)0.7%
ROA(5y)1.11%
ROE(3y)1.64%
ROE(5y)2.4%
ROIC(3y)N/A
ROIC(5y)N/A
AMS Yearly ROA, ROE, ROICAMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • AMS has a Gross Margin of 18.03%. This is in the lower half of the industry: AMS underperforms 60.00% of its industry peers.
  • AMS's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AMS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.82%
GM growth 5Y-6.37%
AMS Yearly Profit, Operating, Gross MarginsAMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. AMS Health Analysis

2.1 Basic Checks

  • AMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AMS has been increased compared to 1 year ago.
  • The number of shares outstanding for AMS has been increased compared to 5 years ago.
  • AMS has a better debt/assets ratio than last year.
AMS Yearly Shares OutstandingAMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
AMS Yearly Total Debt VS Total AssetsAMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • AMS has an Altman-Z score of 0.54. This is a bad value and indicates that AMS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.54, AMS is doing worse than 73.00% of the companies in the same industry.
  • AMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACCN/A
WACC9.08%
AMS Yearly LT Debt VS Equity VS FCFAMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 0.76 indicates that AMS may have some problems paying its short term obligations.
  • AMS has a worse Current ratio (0.76) than 84.00% of its industry peers.
  • A Quick Ratio of 0.76 indicates that AMS may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.76, AMS is not doing good in the industry: 79.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
AMS Yearly Current Assets VS Current LiabilitesAMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. AMS Growth Analysis

3.1 Past

  • The earnings per share for AMS have decreased by -4.55% in the last year.
  • Looking at the last year, AMS shows a decrease in Revenue. The Revenue has decreased by -0.91% in the last year.
  • Measured over the past years, AMS shows a quite strong growth in Revenue. The Revenue has been growing by 9.50% on average per year.
EPS 1Y (TTM)-4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y12.45%
Revenue growth 5Y9.5%
Sales Q2Q%-14.79%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMS Yearly Revenue VS EstimatesAMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AMS Yearly EPS VS EstimatesAMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. AMS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AMS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMS Price Earnings VS Forward Price EarningsAMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • 89.00% of the companies in the same industry are more expensive than AMS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.15
AMS Per share dataAMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMS Dividend Analysis

5.1 Amount

  • No dividends for AMS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMS Fundamentals: All Metrics, Ratios and Statistics

AMERICAN SHARED HOSPITAL SER

NYSEARCA:AMS (4/10/2026, 8:06:01 PM)

1.35

+0.02 (+1.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-31
Earnings (Next)05-07
Inst Owners13.39%
Inst Owner Change0%
Ins Owners35.73%
Ins Owner Change0%
Market Cap8.91M
Revenue(TTM)28.08M
Net Income(TTM)-1.55M
Analysts80
Price Target4.59 (240%)
Short Float %0.02%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.22%
Min Revenue beat(2)-12.86%
Max Revenue beat(2)-5.58%
Revenue beat(4)0
Avg Revenue beat(4)-5.84%
Min Revenue beat(4)-12.86%
Max Revenue beat(4)-0.96%
Revenue beat(8)3
Avg Revenue beat(8)0.24%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF 2.88
P/B 0.37
P/tB 0.39
EV/EBITDA 6.15
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)0.47
OCFY34.77%
SpS4.25
BVpS3.64
TBVpS3.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.8%
ROE -6.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.03%
FCFM N/A
ROA(3y)0.7%
ROA(5y)1.11%
ROE(3y)1.64%
ROE(5y)2.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.82%
GM growth 5Y-6.37%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 133.6%
Cap/Sales 27.18%
Interest Coverage N/A
Cash Conversion 83.73%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z 0.54
F-Score4
WACC9.08%
ROIC/WACCN/A
Cap/Depr(3y)127.88%
Cap/Depr(5y)85.08%
Cap/Sales(3y)28.2%
Cap/Sales(5y)19.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y12.45%
Revenue growth 5Y9.5%
Sales Q2Q%-14.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-213.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1755.09%
OCF growth 3Y-24.64%
OCF growth 5Y-20.49%

AMERICAN SHARED HOSPITAL SER / AMS Fundamental Analysis FAQ

What is the fundamental rating for AMS stock?

ChartMill assigns a fundamental rating of 2 / 10 to AMS.


What is the valuation status for AMS stock?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN SHARED HOSPITAL SER (AMS). This can be considered as Overvalued.


Can you provide the profitability details for AMERICAN SHARED HOSPITAL SER?

AMERICAN SHARED HOSPITAL SER (AMS) has a profitability rating of 2 / 10.